tiprankstipranks
Larimar Therapeutics, Inc. (LRMR)
NASDAQ:LRMR

Larimar Therapeutics (LRMR) Ownership - Who Owns Larimar Therapeutics?

360 Followers

Larimar Therapeutics (LRMR) Ownership Overview

50.76%7.20%8.32%33.72%
50.76% Insiders
8.32% Other Institutional Investors
33.72% Public Companies and Individual Investors
The ownership structure of Larimar Therapeutics (LRMR) stock is a mix of institutional, retail and individual investors. Approximately 15.52% of the company’s stock is owned by Institutional Investors, 50.76% is owned by Insiders and 33.72% is owned by Public Companies and Individual Investors.
The ownership structure of Larimar Therapeutics (LRMR) stock is a mix of institutional, retail and individual investors. Approximately 15.52% of the company’s stock is owned by Institutional Investors, 50.76% is owned by Insiders and 33.72% is owned by Public Companies and Individual Investors.

Recent Insider Trading Activity

Date
Name
Activity
Value
May 31, 2024
xxxxxxxxxxxxx
$499998
Feb 16, 2024
James E. Flynn
Director, >10% Owner,other
xxxxxxxxxxxxx
$37499993
Feb 15, 2024
Frank Thomas
Director
xxxxxxxxxxxxx
$22000
Dec 08, 2023
xxxxxxxxxxxxx
$18650

Recent Hedge Fund Trading Activity

Date
Firm
Activity
Value
Mar 31, 2024
xxxxxxxxxxxxx
$105705
Mar 31, 2024
xxxxxxxxxxxxx
$8259642
Mar 31, 2024
xxxxxxxxxxxxx
$8731027
Mar 31, 2024
xxxxxxxxxxxxx
$45884214

Top Shareholders

Holder
# of Shares
Type
% Holding
Value
21,231,974Institution33.28%197,881,998
6,045,351Institution9.48%56,342,671
4,643,327Insider7.28%43,275,808
4,638,028Insider7.27%43,226,421
2,431,070Institution3.81%22,657,572
2,165,221Institution3.39%20,179,860
1,652,330Institution2.59%15,399,716
1,150,333Institution1.80%10,721,104
1,088,227Institution1.71%10,142,276
474,707Institution0.74%4,424,269

Top Mutual Fund Holders

Holder
# of Shares
Type
% Holding
Value
2,165,221Institution3.39%20,179,860
474,707Institution0.74%4,424,269
439,084Institution0.69%4,092,263
281,529Institution0.44%2,623,850
200,544Institution0.31%1,869,070
181,207Institution0.28%1,688,849
145,505Institution0.23%1,356,107
111,663Institution0.18%1,040,699
88,727Institution0.14%826,936
82,807Institution0.13%771,761

Top ETF Holders

Holder
# of Shares
Type
% Holding
Value
1,108,920Institution1.74%10,335,134
1,341,890Institution2.10%9,728,703
855,591Institution1.34%6,203,035
438,851Institution0.69%4,090,091
373,751Institution0.59%3,483,359
156,618Institution0.25%1,135,481
94,663Institution0.15%882,259
72,305Institution0.11%673,883
33,660Institution0.05%314,048
38,747Institution0.06%280,916

FAQ

Who Owns Larimar Therapeutics, Inc. (LRMR)?
According to the latest TipRanks data, approximately 8.32% of the company's stock is held by institutional investors, 50.76% is held by insiders, and 33.72% is held by retail investors.
    What percentage of Larimar Therapeutics, Inc. (LRMR) stock is held by institutional investors?
    According to the latest TipRanks data, approximately 8.32% of Larimar Therapeutics, Inc. (LRMR) stock is held by institutional investors.
      What percentage of Larimar Therapeutics, Inc. (LRMR) stock is held by retail investors?
      According to the latest TipRanks data, approximately 33.72% of Larimar Therapeutics, Inc. (LRMR) stock is held by retail investors.
        Who owns the most shares of Larimar Therapeutics, Inc. (LRMR)?
        James E. Flynn owns the most shares of Larimar Therapeutics, Inc. (LRMR).
          What is the significance of the ownership structure for a publicly traded company?
          The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
            What's Included in PREMIUM?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis